Limitations in using peptide drugs to characterize calcitonin gene- related peptide receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 3, 1999, Pages 1419-1426

  Waugh, David J J ^a,b   Bookman, Charles S ^a   Smith, D David ^a   Abel, Peter W ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; CAPSAICIN; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG RECEPTOR BINDING; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SMOOTH MUSCLE CONTRACTION; SWINE; VASODILATATION;

ANIMALS; BASILAR ARTERY; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PEPTIDE FRAGMENTS; POTASSIUM CHLORIDE; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; REPRODUCIBILITY OF RESULTS; SUBSTANCE P; SWINE; VASODILATION;

EID: 0033061205     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Amara SG, Jones V, Rosenfeld MG, Ong ES and Evans RM (1982) Alternative RNA processing in calcitonin gene expression generates mRNA encoding different polypeptide products. Nature (Lond) 298:240-244.
2. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
3. Bockman CS, Jeffries WB and Abel PW (1993) Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. J Pharmacol Exp Ther 287:1126-1133.
4. Brain SD, Williams TJ, Tippins JR, Morris HR and MacIntyre I (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature (Lond) 313:54-56.
5. Dennis TB, Fournier A., Cadieux A, Pomerleau F, Jolicoeur FB, St.-Pierre S and Quirion R (1990) hCGRP(8-37), a calcitonin gene-related peptide antagonist revealing CGRP receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 264:123-128.
6. Dennis TB, Fournier A, St.-Pierre S and Quirion R (1989) Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther 261:718-725.
7. Edvinssou L, Gulbenkian S, Wharton J, Jansen I and Polak JM (1989) Peptide containing nerves in the rat femoral artery and vein: An immunocytochemical and vasomotor study. Blood Vessels 26:254-271.
8. Fargeas MJ, Fioramonti J and Bueno L (1985) Calcitonin gene-related peptides: Brain and spinal action on intestinal motility. Peptides 6:1167-1171.
9. Feuerstein G, Willette R and Aiyar N (1995) Clinical perspectives of calcitonin gene-related peptide pharmacology. Can J Physiol Pharmacol 73:1070-1074.
10. Foulkes R, Shaw N, Bose C and Hughes B (1991) Differential vasodilator profile of CGRP in porcine large and small diameter coronary artery rings. Eur J Pharmacol 201:143-149.
11. Franco-Cereceda A, Rudehill A and Lundberg JM (1987) Calcitonin gene-related peptide but not substance P mimics capsaicin-induced coronary vasodilation in the pig. Eur J Pharmacol 142:235-243.
12. Gulbenkian S, Opgaard S, Ekman R, Costa Andrade N, Wharton J, Polak JM, Quirez e Melo J and Edvinsson L (1993) Peptidergic innervation of human epicardial coronary arteries. Circ Res 73:579-588.
13. Hanko J, Hardebo JE, Kahrstrom J, Owman C and Sundler F (1985) CGRP ie present in mammalian cardiovascular nerve fibers and dilates pial and peripheral arteries. Neurosci Lett 57:91-95.
14. Kenakin TP (1993a) Agonist affinity, in Pharmacologic Analysis of Drug-Receptor Interaction pp 221-248, Raven Press, New York.
15. Kenakin TP (1993b) Methods of drug and receptor classification, in Pharmacologic Analysis of Drug-Receptor Interaction pp 344-384, Raven Press, New York.
16. Kenakin TP (1993c) Competitive antagonism, in Pharmacologic Analysis of Drug-Receptor Interaction pp 278-322, Raven Press, New York.
17. Lenz HJ, Mortrud MT, Rivier JE and Brown MR (1985) Central nervous system actions of calcitonin gene-related peptide on gastric acid secretion in the rat. Gastroenterology 88:539-544.
18. Maggi CA, Chiba T and Guiliani S (1991) Human α-calcitonin gene-related peptide (8-37) as an antagonist of exogenous and endogenous calcitonin gene-related peptide. Eur J Pharmacol 192:85-88.
19. Mimeault M, Fournier A, Dumont Y, St.-Pierre S and Quirion R (1991) Comparative affinities and antagonist potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther 258:1084-1090.
20. Poyner DR (1993) Calcitonin gene-related peptide: Multiple actions, multiple receptors. Pharmacol Ther 56:23-53.
21. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW and Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processing. Nature (Lond) 304:129-135.
22. Ruffolo RR (1982) Review: Important concepts of receptor theory. J Auton Pharmacol 2:277-295.
23. Smith DD, Li J, Wang Q, Murphy RF, Adrian TE, Elias Y, Bockman CS and Abel PW (1993) Synthesis and biological activity of C-terminally truncated fragments of human a-calcitonin gene-related peptide. J Med Chem 36:2536-2541.
24. Tannenbaum GS and Goltzmann D (1985) Calcitonin gene related peptide mimics calcitonin action in brain on growth hormone release and feeding. Endocrinology 116:2685-2687.